Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
42
UNH Quote, Financials, Valuation and Earnings
Last price:
$500.35
Seasonality move
:
10.29%
Day range:
$488.73 - $502.64
52-week range:
$436.38 - $630.73
Dividend yield:
1.64%
P/E ratio:
32.58x
P/S ratio:
1.19x
P/B ratio:
4.87x
Volume:
10.9M
Avg. volume:
5.6M
1-year change:
-3.06%
Market cap:
$460.3B
Revenue:
$367.5B
EPS (TTM):
$15.35
Analysts' Opinion
-
Consensus RatingUnitedHealth Group has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $636.05, UnitedHealth Group has an estimated upside of 27.18% from its current price of $500.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $587.12 representing -17.39% downside risk from its current price of $500.13.
Fair Value
-
According to the consensus of 21 analysts, UnitedHealth Group has 27.18% upside to fair value with a price target of $636.05 per share.
UNH vs. S&P 500
-
Over the past 5 trading days, UnitedHealth Group has underperformed the S&P 500 by -1.96% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
UnitedHealth Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UnitedHealth Group has grown year-over-year revenues for 140 quarters straight. In the most recent quarter UnitedHealth Group reported revenues of $99.2B.
Earnings Growth
-
UnitedHealth Group has grown year-over-year earnings for 1 quarter straight. In the most recent quarter UnitedHealth Group reported earnings per share of $6.51.
Enterprise value:
511.1B
EV / Invested capital:
2.80x
Price / LTM sales:
1.19x
EV / EBIT:
21.41x
EV / Revenue:
1.31x
PEG ratio (5yr expected):
--
EV / Free cash flow:
39.02x
Price / Operating cash flow:
35.44x
Enterprise value / EBITDA:
18.31x
Gross Profit (TTM):
$85.3B
Return On Assets:
5.02%
Net Income Margin (TTM):
3.68%
Return On Equity:
14.51%
Return On Invested Capital:
8.46%
Operating Margin:
7.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $313.1B | $356.2B | $389.1B | $91.4B | $99.2B | |
| Gross Profit | $74.3B | $86.1B | $85.3B | $22.4B | $21.4B | |
| Operating Income | $25.1B | $27.8B | $27.4B | $7.5B | $7.1B | |
| EBITDA | $30.3B | $35.5B | $27.9B | $9.5B | $9.7B | |
| Diluted EPS | $20.42 | $23.04 | $15.35 | $6.24 | $6.51 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $54.8B | $61.6B | $82.9B | $91.9B | $92.3B | |
| Total Assets | $191B | $213B | $243.1B | $282.1B | $299.3B | |
| Current Liabilities | $66.6B | $79.6B | $100.9B | $114.2B | $101.6B | |
| Total Liabilities | $121B | $138.4B | $160.1B | $188.1B | $194.9B | |
| Total Equity | $70B | $74.6B | $82.9B | $94B | $104.5B | |
| Total Debt | $43.8B | $47B | $48.7B | $63.4B | $78B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $34B | $29.7B | $16.6B | $6.9B | $13.9B | |
| Cash From Investing | -$12.4B | -$29.8B | -$20.6B | -$2.6B | -$5.7B | |
| Cash From Financing | -$3.8B | $19M | -$2.3B | -$7.1B | -$2.2B | |
| Free Cash Flow | $31.3B | $26.4B | $13.1B | $6.1B | $13B | |
UNH
Sector
Market Cap
$460.3B
$44.6M
Price % of 52-Week High
79.29%
45.71%
Dividend Yield
1.64%
0%
Shareholder Yield
1.57%
-0.68%
1-Year Price Total Return
-3.06%
-29.09%
Beta (5-Year)
0.583
0.772
Dividend yield:
1.64%
Annualized payout:
$7.29
Payout ratio:
51.26%
Growth streak:
14 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$505.36
200-day SMA
Sell
Level
$538.26
Bollinger Bands (100)
Sell
Level
551.14 - 604.22
Chaikin Money Flow
Buy
Level
322.3M
20-day SMA
Sell
Level
$557.20
Relative Strength Index (RSI14)
Sell
Level
33.94
ADX Line
Neutral
Level
Williams %R
Buy
Level
-83.4637
50-day SMA
Sell
Level
$572.69
MACD (12, 26)
Sell
Level
-26.01
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
527.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8021)
Buy
CA Score
(Annual)
Level (-0.171)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.1751)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Stock Forecast FAQ
In the current month, UNH has received 18 Buy ratings 3 Hold ratings, and 0 Sell ratings. The UNH average analyst price target in the past 3 months is $636.05.
-
Where Will UnitedHealth Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that UnitedHealth Group share price will rise to $636.05 per share over the next 12 months.
-
What Do Analysts Say About UnitedHealth Group?
Analysts are divided on their view about UnitedHealth Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group is a Sell and believe this share price will drop from its current level to $587.12.
-
What Is UnitedHealth Group's Price Target?
The price target for UnitedHealth Group over the next 1-year time period is forecast to be $636.05 according to 21 Wall Street analysts, 18 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is UNH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UnitedHealth Group is a Buy. 18 of 21 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of UNH?
You can purchase shares of UnitedHealth Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group shares.
-
What Is The UnitedHealth Group Share Price Today?
UnitedHealth Group was last trading at $500.35 per share. This represents the most recent stock quote for UnitedHealth Group. Yesterday, UnitedHealth Group closed at $500.13 per share.
-
How To Buy UnitedHealth Group Stock Online?
In order to purchase UnitedHealth Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
